ARDULEON
Live / Applied — New application — assigned to an examiner (as of 07 Sept 2026)
What this means for you
Not registered yet, but its 04 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99802841
- Mark type
- Stylized text
- Filed
- 04 May 2026
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Antivirals; Antibodies for medical purposes; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder, and musculoskeletal and skin diseases; Biological preparations for the treatment of cancer
Owner
- Celgene Corporation, Princeton, NJ, US
Prosecution history
- 07 Sept 2026 — ASSIGNED TO EXAMINER
- 06 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 May 2026 — APPLICATION FILING RECEIPT MAILED
- 04 May 2026 — NEW APPLICATION ENTERED